← Back to Search

Support-t Online Training for Type 1 Diabetes Transition Care (Support-t Trial)

N/A

Waitlist Available

Led By Anne-Sophie Brazeau, PhD

Research Sponsored by McGill University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6, 12, 18 months

Awards & highlights

Support-t Trial Summary

This trial will study how an online training and peer support platform can help teens with Type 1 Diabetes transition to adult care.

Who is the study for?

This trial is for 14-16 year olds with Type 1 Diabetes who are patients at one of four specific pediatric diabetes clinics in Quebec. They must have internet access, an active email, and speak English or French. It's not specified who can't join.Check my eligibility

What is being tested?

The study tests 'Support-t', an online training and peer support platform designed to help youths with Type 1 Diabetes as they prepare to move from child to adult care services. The effect on blood sugar control, health outcomes, and mental well-being will be compared with usual care.See study design

What are the potential side effects?

Since 'Support-t' is a non-medical intervention focusing on education and social support, it does not have typical medical side effects. However, participants may experience stress or anxiety related to the use of technology or the transition process.

Support-t Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6, 12, 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6, 12, 18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6, 12, 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from Baseline Hemaglobin A1c (HbA1c) at 18 months

Secondary outcome measures

Change from Baseline Hemaglobin A1c (HbA1c) at 6 and 12 months

Continuous Glucose Monitoring (CGM) - % Coefficient of variation

Continuous Glucose Monitoring (CGM) - % Time above range

+15 more

Other outcome measures

Engagement with Support-t platform (Health Care Provider) - content accessed

Engagement with Support-t platform (Health Care Provider) - downloaded documents

Engagement with Support-t platform (Health Care Provider) - time in minutes on platform

+11 more

Support-t Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Support-t plus usual diabetes careExperimental Treatment1 Intervention

Access to the Support-t online training and peer support platform in addition to usual diabetes care for 18 months. Support-t contains 3 components: 1) Educational material, 2) News blog and 3) Patients' discussion forum. Health care providers from the pediatric diabetes clinics will receive Support-t training and will be encouraged to recommend the Support-t platform during routine care with their patients from the active arm.

Group II: Usual diabetes care onlyActive Control1 Intervention

Usual diabetes care for 18 months, which consists of visits with their health care provider and ad-hoc diabetes education with nurses and dietitians. Health care providers from the pediatric diabetes clinics will be instructed not to discuss or refer to the Support-t platform with patients from the control arm. Control arm participants will have the option to use the Support-t platform after the 18-month study.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

CHU de Quebec-Universite LavalOTHER

167 Previous Clinical Trials

106,957 Total Patients Enrolled

9 Trials studying Diabetes Mellitus

970 Patients Enrolled for Diabetes Mellitus

McGill UniversityLead Sponsor

394 Previous Clinical Trials

998,181 Total Patients Enrolled

23 Trials studying Diabetes Mellitus

783,630 Patients Enrolled for Diabetes Mellitus

McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER

442 Previous Clinical Trials

158,974 Total Patients Enrolled

17 Trials studying Diabetes Mellitus

6,286 Patients Enrolled for Diabetes Mellitus

Media Library

Support-t Clinical Trial Eligibility Overview. Trial Name: NCT05910840 — N/A

Diabetes Mellitus Research Study Groups: Support-t plus usual diabetes care, Usual diabetes care only

Diabetes Mellitus Clinical Trial 2023: Support-t Highlights & Side Effects. Trial Name: NCT05910840 — N/A

Support-t 2023 Treatment Timeline for Medical Study. Trial Name: NCT05910840 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research study available to those of senior age?

"This clinical trial requires patients between the ages of 14 and 16 to participate. Globally, there are 285 trials for individuals under 18 years old and 1092 studies devoted to those over 65."

Answered by AI

Is it permissible for me to register for this clinical experiment?

"Individuals between the ages of 14 and 16 who suffer from diabetes are eligible to participate in this research trial. 200 participants are needed for a successful outcome."

Answered by AI

How many locations are conducting this experiment?

"As of now, 4 sites for this research study have been identified. People can participate in Montréal, Québec or Sherbrooke along with 2 other areas. To reduce the amount of travelling needed, selecting the closest location is highly recommended if you choose to join."

Answered by AI

Is it feasible to enroll in this clinical trial at the current time?

"As per clinicaltrials.gov, this medical research is no longer recruiting patients; the trial was first posted on November 1st 2023 and last modified June 16th 2023. Despite being inactive, 1498 other studies are currently enrolling volunteers at present."

Answered by AI

Recent research and studies

Diabetic MedicineJournal

Toward a Better Understanding of Transition from Paediatric to Adult Care in Type 1 Diabetes: A Qualitative Study of Adolescents

Ladd, Jennifer M., Jonathan Reeves‐Latour, Kaberi Dasgupta, Lorraine E Bell, Nadia Anjachak, and Meranda Nakhla. 2022. “Toward a Better Understanding of Transition from Paediatric to Adult Care in Type 1 Diabetes: A Qualitative Study of Adolescents”. Diabetic Medicine. Wiley. doi:10.1111/dme.14781.

BMJ OpenJournal

Group Education for Adolescents with Type 1 Diabetes During Transition from Paediatric to Adult Care: Study Protocol for a Multisite, Randomised Controlled, Superiority Trial (GET-IT-T1D)

Mok, Elise, Melanie Henderson, Kaberi Dasgupta, Elham Rahme, Mohammad Hajizadeh, Lorraine Bell, Melinda Prevost, Jennifer Frei, and Meranda Nakhla. 2019. “Group Education for Adolescents with Type 1 Diabetes During Transition from Paediatric to Adult Care: Study Protocol for a Multisite, Randomised Controlled, Superiority Trial (GET-IT-T1D)”. BMJ Open. BMJ. doi:10.1136/bmjopen-2019-033806.

Canadian Journal of DiabetesJournal

Association of Self-efficacy, Transition Readiness and Diabetes Distress with Glycemic Control in Adolescents with Type 1 Diabetes Preparing to Transition to Adult Care

Alwadiy, Faisal, Elise Mok, Kaberi Dasgupta, Elham Rahme, Jennifer Frei, and Meranda Nakhla. 2021. “Association of Self-efficacy, Transition Readiness and Diabetes Distress with Glycemic Control in Adolescents with Type 1 Diabetes Preparing to Transition to Adult Care”. Canadian Journal of Diabetes. Elsevier BV. doi:10.1016/j.jcjd.2021.05.006.

Diabetic MedicineJournal